78 related articles for article (PubMed ID: 1907244)
1. [The effect of glibenclamide on the spontaneous evolution of genetically determined diabetes mellitus in C57BL/KsJY db+/+db mice].
Poltorak VV; Gladkikh AI; Blokh KO; Brindak OI; Berestovskaia EV; Tur MI
Farmakol Toksikol; 1991; 54(1):34-7. PubMed ID: 1907244
[TBL] [Abstract][Full Text] [Related]
2. [Effect of gene db dose on the development of beta-cytotropic and immunotropic effects of long-term glibenclamide administration in C57BL/KsJY mice].
Gladkikh AI; Poltorak VV; Brindak OI; Blokh KO; Berestovskaia EV; Koshel' SP
Tsitol Genet; 1992; 26(1):20-6. PubMed ID: 1621282
[TBL] [Abstract][Full Text] [Related]
3. Estrogenic restoration of functional pancreatic islet cytoarchitecture in diabetes (db/db) mutant C57BL/KsJ mice: relationship to estradiol localization, systemic glycemia, and persistent hyperinsulinemia.
Garris DR; Garris BL
Cell Tissue Res; 2005 Feb; 319(2):231-42. PubMed ID: 15654653
[TBL] [Abstract][Full Text] [Related]
4. [The effect of irradiation on the development of streptozotocin diabetes in C57BL/KsJY mice heterozygous and homozygous for gene db (diabetes)].
Blokh KO; Blokh OV; Poltorak VV; Brindak OI
Radiobiologiia; 1991; 31(1):43-7. PubMed ID: 2008522
[TBL] [Abstract][Full Text] [Related]
5. [Effect of mutant genes db(diabetes) and m(misty) on the severity of high-dose streptozotocin diabetes in C57bl/KsJY mice].
Blokh KO; Poltorak VV; Brindak OI
Tsitol Genet; 1991; 25(1):58-61. PubMed ID: 1866786
[TBL] [Abstract][Full Text] [Related]
6. [The effect of long-term glibenclamide administration on pancreatic beta cells and on autoimmunity indices].
Poltorak VV; Gladkikh AI; Brindak OI; Blokh KO
Farmakol Toksikol; 1990; 53(6):40-3. PubMed ID: 2127921
[TBL] [Abstract][Full Text] [Related]
7. Effect of immunodeficiency on diabetogenesis in genetically diabetic (db/db) mice.
Leiter EH; Prochazka M; Shultz LD
J Immunol; 1987 May; 138(10):3224-9. PubMed ID: 3553324
[TBL] [Abstract][Full Text] [Related]
8. Reduction of oxidative stress by a new low-molecular-weight antioxidant improves metabolic alterations in a nonobese mouse diabetes model.
Novelli M; D'Aleo V; Lupi R; Paolini M; Soleti A; Marchetti P; Masiello P
Pancreas; 2007 Nov; 35(4):e10-7. PubMed ID: 18090226
[TBL] [Abstract][Full Text] [Related]
9. Acceleration of the development of diabetes in obese diabetic (db/db) mice by nicotinamide: a comparison with its antidiabetic effects in non-obese diabetic mice.
Piercy V; Toseland CD; Turner NC
Metabolism; 2000 Dec; 49(12):1548-54. PubMed ID: 11145115
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic autoimmunity induction with insulin B:9-23 peptide and viral mimics in the NZB mouse.
Devendra D; Miao D; Nakayama M; Eisenbarth GS; Liu E
Ann N Y Acad Sci; 2006 Oct; 1079():135-7. PubMed ID: 17130544
[TBL] [Abstract][Full Text] [Related]
11. [Study of diabetogenic and lympholytic effects during single and fractional administration of streptozotocin to mice of the mutant strain C57BL/KsIY-db/m].
Blokh KO; Poltorak VV; Blokh OV
Vopr Med Khim; 1991; 37(1):42-3. PubMed ID: 1830435
[TBL] [Abstract][Full Text] [Related]
12. Combination of dipeptidylpeptidase IV inhibitor and low dose thiazolidinedione: preclinical efficacy and safety in db/db mice.
Roy S; Khanna V; Mittra S; Dhar A; Singh S; Mahajan DC; Priyadarsiny P; Davis JA; Sattigeri J; Saini KS; Bansal VS
Life Sci; 2007 Jun; 81(1):72-9. PubMed ID: 17532347
[TBL] [Abstract][Full Text] [Related]
13. PEGylation improves the hypoglycaemic efficacy of intranasally administered glucagon-like peptide-1 in type 2 diabetic db/db mice.
Youn YS; Jeon JE; Chae SY; Lee S; Lee KC
Diabetes Obes Metab; 2008 Apr; 10(4):343-6. PubMed ID: 18034839
[TBL] [Abstract][Full Text] [Related]
14. Genetic control of low-dose streptozotocin-induced autoimmune diabetes in mice.
Kiesel U; Falkenberg FW; Kolb H
J Immunol; 1983 Apr; 130(4):1719-22. PubMed ID: 6833751
[TBL] [Abstract][Full Text] [Related]
15. [The effect of dopaminergic pharmacological agents on the pancreatic islet apparatus in rats].
Boiadzhieva N
Eksp Med Morfol; 1990; 29(3):20-6. PubMed ID: 1980459
[TBL] [Abstract][Full Text] [Related]
16. Anti-diabetic effects of electrolyzed reduced water in streptozotocin-induced and genetic diabetic mice.
Kim MJ; Kim HK
Life Sci; 2006 Nov; 79(24):2288-92. PubMed ID: 16945392
[TBL] [Abstract][Full Text] [Related]
17. Separate influences of insulin and hyperglycemia on hepatic drug metabolism in mice with genetic and chemically induced diabetes mellitus.
Knodell RG; Handwerger BS; Morley JE; Levine AS; Brown DM
J Pharmacol Exp Ther; 1984 Jul; 230(1):256-62. PubMed ID: 6379147
[TBL] [Abstract][Full Text] [Related]
18. Tetrathiomolybdate is partially protective against hyperglycemia in rodent models of diabetes.
Zeng C; Hou G; Dick R; Brewer GJ
Exp Biol Med (Maywood); 2008 Aug; 233(8):1021-5. PubMed ID: 18480419
[TBL] [Abstract][Full Text] [Related]
19. Antidiabetic and toxicological evaluations of naringenin in normoglycaemic and NIDDM rat models and its implications on extra-pancreatic glucose regulation.
Ortiz-Andrade RR; Sánchez-Salgado JC; Navarrete-Vázquez G; Webster SP; Binnie M; García-Jiménez S; León-Rivera I; Cigarroa-Vázquez P; Villalobos-Molina R; Estrada-Soto S
Diabetes Obes Metab; 2008 Nov; 10(11):1097-104. PubMed ID: 18355329
[TBL] [Abstract][Full Text] [Related]
20. Acetaminophen normalizes glucose homeostasis in mouse models for diabetes.
Shertzer HG; Schneider SN; Kendig EL; Clegg DJ; D'Alessio DA; Genter MB
Biochem Pharmacol; 2008 Mar; 75(6):1402-10. PubMed ID: 18237716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
